PMC:7461420 / 19093-19294 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T107","span":{"begin":77,"end":84},"obj":"Body_part"},{"id":"T108","span":{"begin":168,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A107","pred":"fma_id","subj":"T107","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A108","pred":"fma_id","subj":"T108","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"51 Imatinib (6; Figure 4), an Abelson kinase inhibitor, could inhibit CoV S protein‐induced fusion with an EC50 value of 10 µM and showed no cytotoxic effects in Vero cells up to 100 µM concentration."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T214","span":{"begin":163,"end":167},"obj":"http://purl.obolibrary.org/obo/CLO_0009524"},{"id":"T215","span":{"begin":163,"end":167},"obj":"http://purl.obolibrary.org/obo/CLO_0050515"},{"id":"T216","span":{"begin":168,"end":173},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"51 Imatinib (6; Figure 4), an Abelson kinase inhibitor, could inhibit CoV S protein‐induced fusion with an EC50 value of 10 µM and showed no cytotoxic effects in Vero cells up to 100 µM concentration."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T146","span":{"begin":46,"end":55},"obj":"Chemical"},{"id":"T147","span":{"begin":77,"end":84},"obj":"Chemical"}],"attributes":[{"id":"A146","pred":"chebi_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A147","pred":"chebi_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"51 Imatinib (6; Figure 4), an Abelson kinase inhibitor, could inhibit CoV S protein‐induced fusion with an EC50 value of 10 µM and showed no cytotoxic effects in Vero cells up to 100 µM concentration."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T17","span":{"begin":39,"end":55},"obj":"http://purl.obolibrary.org/obo/GO_0033673"}],"text":"51 Imatinib (6; Figure 4), an Abelson kinase inhibitor, could inhibit CoV S protein‐induced fusion with an EC50 value of 10 µM and showed no cytotoxic effects in Vero cells up to 100 µM concentration."}

{"project":"LitCovid-PubTator","denotations":[{"id":"601","span":{"begin":71,"end":74},"obj":"Species"},{"id":"602","span":{"begin":4,"end":12},"obj":"Chemical"}],"attributes":[{"id":"A601","pred":"tao:has_database_id","subj":"601","obj":"Tax:11118"},{"id":"A602","pred":"tao:has_database_id","subj":"602","obj":"MESH:D000068877"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"51 Imatinib (6; Figure 4), an Abelson kinase inhibitor, could inhibit CoV S protein‐induced fusion with an EC50 value of 10 µM and showed no cytotoxic effects in Vero cells up to 100 µM concentration."}

{"project":"LitCovid-sentences","denotations":[{"id":"T190","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"51 Imatinib (6; Figure 4), an Abelson kinase inhibitor, could inhibit CoV S protein‐induced fusion with an EC50 value of 10 µM and showed no cytotoxic effects in Vero cells up to 100 µM concentration."}